TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH
TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection
Sponsor BioNTech SE
- Start (EU)
- Latest update
- Estimated end
Open-label, randomized Phase II trial with BNT111 and cemiplimab in combination or as single agents in patients with anti-PD-1/PD-L1-refractory/relapsed, unresectable Stage III or IV melanoma
Sponsor BioNTech SE
- Start (EU)
- Latest update
- Estimated end
Operational learnings available1 trial-level finding · Read insights
- A local CRO reporting error in Italy communicated an implausible BNT111 stability out-of-specification result as an urgent safety measure, resulting in a temporary clinical halt and enrollment suspension from 05 November to 17 December 2021.
These findings describe the trial, not the service provider’s performance or responsibility.
Questions about this trial experience
What services are recorded for TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH?
The 2026-10-09 snapshot links TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH to 2 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH conducted?
The linked trials record locations in 6 countries, including Germany, Spain, Belgium, Italy, Poland. These are trial locations, not confirmed office locations or countries where TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH delivered services.
What can this page tell me about TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz gGmbH